PCG
BIO icon

Private Capital Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Private Capital Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$62K Sell
126
-1
-0.8% -$521 0.05% 402
2022
Q1 		$72K Sell
127
-24
-16% -$14.5K 0.02% 513
2021
Q4 		$114K Hold
151
– – 0.02% 383
2021
Q3 		$113K Buy
151
+2
+1% +$1.5K 0.03% 389
2021
Q2 		$96K Buy
149
+8
+6% +$4.87K 0.02% 425
2021
Q1 		$81K Sell
141
-259
-65% -$153K 0.02% 458
2020
Q4 		$233K Buy
400
+33
+9% +$18.8K 0.04% 272
2020
Q3 		$189K Sell
367
-45
-11% -$22.8K 0.04% 293
2020
Q2 		$186K Sell
412
-26
-6% -$11.5K 0.04% 296
2020
Q1 		$154K Buy
438
+18
+4% +$6.62K 0.04% 298
2019
Q4 		$155K Buy
420
+28
+7% +$9.87K 0.03% 327
2019
Q3 		$130K Buy
392
+370
+1,682% +$121K 0.02% 398
2019
Q2 		$6K Sell
22
-368
-94% -$110K ﹤0.01% 1574
2019
Q1 		$119K Buy
390
+280
+255% +$75.6K 0.02% 405
2018
Q4 		$26K Buy
110
+39
+55% +$10.5K 0.01% 975
2018
Q3 		$22K Buy
71
+49
+223% +$15.2K ﹤0.01% 1099
2018
Q2 		$6K Buy
22
+2
+10% +$552 ﹤0.01% 1593
2018
Q1 		$5K Buy
20
+8
+67% +$2.04K ﹤0.01% 1580
2017
Q4 		$3 Buy
+12
New +$2.91K ﹤0.01% 1748

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Private Capital Group's BIO Position: Q2 2022 in Review

Private Capital Group reduced its Bio-Rad Laboratories Class A (BIO) stake by 0.79% in Q2 2022, selling an estimated $521 and leaving 126 shares worth $62K. The position accounts for 0.05% of the portfolio, ranked #402.

Private Capital Group first reported a position in BIO in Q4 2017 and has held it in 19 quarters since. The position peaked at $233K in Q4 2020. 501 funds tracked by Wall St. Rank hold BIO as of Q2 2022.

  • Private Capital Group held 126 shares of Bio-Rad Laboratories Class A worth $62K as of Q2 2022.
  • Private Capital Group sold 1 Bio-Rad Laboratories Class A share in Q2 2022, an estimated $521.
  • Bio-Rad Laboratories Class A made up 0.05% of Private Capital Group's portfolio in Q2 2022, its #402 holding.
  • Private Capital Group first reported a position in Bio-Rad Laboratories Class A in Q4 2017 and has held it in 19 quarters since.
  • Private Capital Group's Bio-Rad Laboratories Class A position peaked at $233K in Q4 2020.
  • 501 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.